Overview
Poonam Lavaju practices in Dharan, Nepal. Ms. Lavaju is rated as an Experienced expert by MediFind in the treatment of Glaucoma. Her top areas of expertise are Orbital Cellulitis, Periorbital Cellulitis, Chemosis, Lacrimal Gland Tumor, and Trabeculectomy.
Her clinical research consists of co-authoring 24 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Glaucoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Orbital CellulitisMs. Lavaju isDistinguished. Learn about Orbital Cellulitis.
- Advanced
- Cavernous Sinus ThrombosisMs. Lavaju isAdvanced. Learn about Cavernous Sinus Thrombosis.
- ChemosisMs. Lavaju isAdvanced. Learn about Chemosis.
- Lacrimal Gland TumorMs. Lavaju isAdvanced. Learn about Lacrimal Gland Tumor.
- Periorbital CellulitisMs. Lavaju isAdvanced. Learn about Periorbital Cellulitis.
- Experienced
- CellulitisMs. Lavaju isExperienced. Learn about Cellulitis.
- Congenital CataractMs. Lavaju isExperienced. Learn about Congenital Cataract.
- Diabetic KetoacidosisMs. Lavaju isExperienced. Learn about Diabetic Ketoacidosis.
- GlaucomaMs. Lavaju isExperienced. Learn about Glaucoma.
- HemangiomaMs. Lavaju isExperienced. Learn about Hemangioma.
- Inflammatory Myofibroblastic TumorMs. Lavaju isExperienced. Learn about Inflammatory Myofibroblastic Tumor.